Relapsed and/or Refractory Multiple Myeloma (RRMM)
4 clinical trials · Condition
◉ Watch Relapsed and/or Refractory Multiple Myeloma (RRMM)
| Record | Firm | Date |
|---|---|---|
| A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM) (NCT04776018) | Takeda | 2021-04-20 |
Track Relapsed and/or Refractory Multiple Myeloma (RRMM) automatically
Every clearance here is in the API, with alerts when new ones post.